Tarsus Pharmaceuticals, Inc. TARS Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Tarsus Pharmaceuticals, Inc. (TARS) reported comprehensive income (loss), net of tax, attributable to parent of -$7.65M in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s comprehensive income (loss), net of tax, attributable to parent increased by 69.7% year-over-year, from -$25.21M to -$7.65M.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Over 4 years (2021 to 2025), Tarsus Pharmaceuticals, Inc.'s comprehensive income (loss), net of tax, attributable to parent has grown at a 47.9% compound annual growth rate (CAGR), from -$13.83M to -$66.22M.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- This metric represents the total change in equity resulting from both net income and other comprehensive income items, such as unrealized gains or losses on securities. It provides a holistic view of the company's financial performance by including non-owner changes in equity that are typically excluded from the standard net income calculation. This figure is essential for understanding the total impact of all financial activities on the company's net worth.